Efficacy and Tolerability of Riluzole in Treatment Resistant Depression

Conditions

Depression

What is the purpose of this trial?

This study aims to examine the antidepressant efficacy of riluzole, employing a randomized, double-blind, placebo-controlled, adjunctive trial in treatment-resistant major depressive disorder (TRD).


Participation Guidelines

Age:
18 Years - 65 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
National Institute of Mental Health
Yale University
Dates:
08/27/2010
Last Updated:
Study HIC#:
0903004917